Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): Pathology, prognosis, and proposed classification

American Journal of Surgical Pathology

Volumn 30, Issue 5, 2006, Pages 614-624

  McKenney, Jesse K ^a,b   Balzer, Bonnie L ^a,c   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Atypical proliferative; Implants; Low malignant potential; Lymph node; Ovary; Serous borderline tumor

Indexed keywords

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; ENDOSALPINGIOSIS; EOSINOPHILIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MESENTERY LYMPH NODE; OVARY TUMOR; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PREDICTION; PROGNOSIS; SURVIVAL RATE; UTERINE TUBE DISEASE; UTERINE TUBE MUCOSA; CLASSIFICATION; CYSTADENOCARCINOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

ADULT; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33745012688     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000194743.33540.e6     Document Type: Article

References (28)

1. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 1989;28:189-190.
2. Alvarez AA, Moore WF, Robboy SJ, et al. K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary. Gynecol Oncol. 2001;80:201-206.
3. Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology. 2002;40:237-244.
4. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol. 1990;21:397-403.
5. Bell DA, Scully RE. Lymph node involvement by ovarian serous borderline tumors. Mod Pathol. 1992;5:61A.
6. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer. 1988;62:2212-2222.
7. Bell DA, Longacre TA, Prat J, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol. 2004;35:934-948.
8. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001;25:419-432.
9. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20:1319-1330.
10. Clement PB, Young RH, Oliva E, et al. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor: a report of two cases associated with ovarian neoplasms. Mod Pathol. 1996;9:879-886.
11. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999;23:397-409.
12. Gershenson DM, Silva EG, Levy L, et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998;82:1096-1103.
13. Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer. 1998;83:2157-2163.
14. Kadar N, Krumerman M. Possible metaplastic origin of lymph node 'metastases' in serous ovarian tumor of low malignant potential (borderline serous tumor). Gynecol Oncol. 1995;59:394-397.
15. Kurman RJ, Seidman JD, Shih IM. Serous borderline tumours of the ovary. Histopathology. 2005;47:310-315.
16. Leake JF. Tumors of low malignant potential. Curr Opin Obstet Gynecol. 1992;4:81-85.
17. Leake JF, Rader JS, Woodruff JD, et al. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol. 1991;42:124-130.
18. Lee KR, Tavassoli FA, Prat J, et al. Tumours of the ovary and peritoneum. In: Tavassoli FA, Devillee P, eds. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003: 119-124.
19. Longacre TA, Kempson RL, Hendrickson MR. Serous tumours of low malignant potential (serous borderline tumours): moving toward detente. Histopathology. 2005;47:315-318.
20. Longacre TA, McKenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol. 2005;29:707-723.
21. Moore WF, Bentley RC, Berchuck A, et al. Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary. Am J Surg Pathol. 2000;24:710-718.
22. Rao GG, Skinner E, Gehrig PA, et al. Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol. 2004;104:261-266.
23. Rollins SE, Young RH, Bell DA. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol. 2006;30:457-462.
24. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539-557.
25. Sherman ME, Mink PJ, Curtis R, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer. 2004;100:1045-1052.
26. Shiraki M, Otis CN, Donovan JT, et al. Ovarian serous borderine epithelial tumors with multiple retroperitoneal nodal involvement: metastasis or malignant transformation of epithelial glandular inclusions? Gynecol Oncol. 1992;46:255-258.
27. Tan LK, Flynn SD, Carcangiu ML. Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the literature. Am J Surg Pathol. 1994;18:904-912.
28. Winter WE 3rd, Kucera PR, Rodgers W, et al. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol. 2002;100:671-676.